Clover Health Investments, Corp. (CLOV)

Clover Health Investments experienced significant insider trading activity recently, with executives offloading over $2.1 million in net value. These transactions occurred following a strong earnings report where the company beat expectations. Despite the selling pressure, the stock price remains elevated, trading near its fifty-two-week high after a 17.3% gain over the past quarter.
Ticker: CLOV Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Clover Health Investments, Corp.. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.3
THORNTON JOSEPH CLAY Chief Financial Officer Officer
Transaction date
Sale
Price
384.11
Quantity 22,161 -0.3%
Value US$84,252
1.3
Joseph Clay Thornton Officer Officer
Transaction date
Proposed sale
Price
335.02
Quantity 15,034
Value US$2,970,696
3.5
Soares Karen Chief Legal Officer Officer
Transaction date
Planned sale
Price
267.53
Quantity 34,314 -20.4%
Value US$1,130,487
3.5
KAREN SOARES Officer Officer
Transaction date
Proposed sale
Price
4.44
Quantity 19,275
Value US$85,581
2.4
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
4.41
Quantity 4,066 -0.1%
Value US$17,931
2.4
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
4.48
Quantity 4,066
Value US$18,216
3.1
Toy Andrew Chief Executive Officer Executive Director
Transaction date
Sale
Price
4.68
Quantity 62,176 -0.7%
Value US$290,984
3.5
Soares Karen Chief Legal Officer Officer
Transaction date
Sale
Price
4.68
Quantity 14,673 -0.9%
Value US$68,670
1.3
THORNTON JOSEPH CLAY Interim CFO Officer
Transaction date
Sale
Price
4.68
Quantity 4,591 -0.4%
Value US$21,486
1.6
Wai Conrad CEO, Counterpart Health Officer
Transaction date
Sale
Price
4.68
Quantity 23,627 -2.2%
Value US$110,574
2.4
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Sale
Price
4.68
Quantity 18,273 -0.7%
Value US$85,518
3.1
Andrew Toy Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 60,765
Value US$284,380
1.3
Joseph Clay Thornton Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 4,487
Value US$20,999
1.6
Conrad Wai Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 23,463
Value US$109,807
3.5
Karen M. Soares Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 14,341
Value US$67,116
2.4
Jamie Reynoso Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 17,858
Value US$83,575
2.4
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
4.63
Quantity 2,006 -0.1%
Value US$9,288
2.4
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
4.60
Quantity 2,006
Value US$9,228
2.4
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Sale
Price
4.42
Quantity 8,750 -0.3%
Value US$38,675
2.4
Jamie Reynoso Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 8,706
Value US$40,744
3.1
Toy Andrew Chief Executive Officer Executive Director
Transaction date
Sale
Price
4.19
Quantity 318,806 -3.4%
Value US$1,335,797
3.1
Andrew Toy Officer Officer
Transaction date
Proposed sale
Price
4.23
Quantity 309,558
Value US$1,309,430
1.9
BRADY PRIEST Former Officer Officer
Transaction date
Proposed sale
Price
4.46
Quantity 141,418
Value US$631,163
2.4
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
4.56
Quantity 1,921 -0.1%
Value US$8,760
2.4
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
4.56
Quantity 1,921
Value US$8,760
2.4
OLDAKOWSKI JOSEPH FRANK VP OF FINANCE AND CONTROLLER Officer
Transaction date
Sale
Price
4.64
Quantity 3,170 -1.1%
Value US$14,709
2.4
Joseph Frank Oldakowski Officer Officer
Transaction date
Proposed sale
Price
4.64
Quantity 3,170
Value US$14,709
1.6
Wai Conrad CEO, Counterpart Health Officer
Transaction date
Planned sale
Price
4.72
Quantity 300,000 -20.4%
Value US$1,416,000
3.5
Soares Karen Chief Legal Officer Officer
Transaction date
Sale
Price
4.78
Quantity 6,846 -0.4%
Value US$32,724
2.4
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Sale
Price
4.78
Quantity 9,273 -0.3%
Value US$44,325
3.5
Karen Soares Officer Officer
Transaction date
Proposed sale
Price
4.66
Quantity 6,416
Value US$29,899
2.4
Jamie Reynoso Officer Officer
Transaction date
Proposed sale
Price
4.66
Quantity 8,691
Value US$40,500
1.9
BRADY PRIEST Former Officer Officer
Transaction date
Proposed sale
Price
4.64
Quantity 215,291
Value US$999,575
1.6
WAI CONRAD Officer Officer
Transaction date
Proposed sale
Price
4.72
Quantity 300,000
Value US$1,417,022
2.4
OLDAKOWSKI JOSEPH FRANK VP OF FINANCE AND CONTROLLER Officer
Transaction date
Sale
Price
5.16
Quantity 20,000 -6.7%
Value US$103,200
2.4
JOSEPH OLDAKOWSKI Officer Officer
Transaction date
Proposed sale
Price
5.16
Quantity 20,000
Value US$103,100
1.9
BRADY PRIEST Officer Officer
Transaction date
Proposed sale
Price
4.15
Quantity 73,516
Value US$305,113
1.3
THORNTON JOSEPH CLAY Interim CFO Officer
Transaction date
Sale
Price
4.39
Quantity 17,775 -1.4%
Value US$78,032
1.3
Joseph Clay Thornton Officer Officer
Transaction date
Proposed sale
Price
4.27
Quantity 16,942
Value US$72,342
1.9
BRADY PRIEST Officer Officer
Transaction date
Proposed sale
Price
4.57
Quantity 474,801
Value US$2,171,597
3.1
Toy Andrew Chief Executive Officer Executive Director
Transaction date
Sale
Price
4.65
Quantity 87,798 -0.9%
Value US$408,261
3.1
Andrew Toy Officer Officer
Transaction date
Proposed sale
Price
4.57
Quantity 85,704
Value US$391,667
1.9
BRADY PRIEST Officer Officer
Transaction date
Proposed sale
Price
4.85
Quantity 441,601
Value US$2,141,989
3.5
Soares Karen Chief Legal Officer Officer
Transaction date
Planned sale
Price
4.51
Quantity 51,700 -3.3%
Value US$233,167
3.5
KAREN SOARES Officer Officer
Transaction date
Proposed sale
Price
4.62
Quantity 51,700
Value US$238,854
2.4
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
4.53
Quantity 4,839 -0.2%
Value US$21,921
2.4
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
4.40
Quantity 4,839
Value US$21,292
3.1
Toy Andrew Chief Executive Officer Executive Director
Transaction date
Sale
Price
4.67
Quantity 62,711 -0.7%
Value US$292,860
1.6
Wai Conrad CEO, Counterpart Health Officer
Transaction date
Sale
Price
4.67
Quantity 24,215 -2.1%
Value US$113,084
2.4
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Sale
Price
4.67
Quantity 13,119 -0.5%
Value US$61,266
3.5
Soares Karen Chief Legal Officer Officer
Transaction date
Sale
Price
4.67
Quantity 10,519 -0.7%
Value US$49,124
1.3
THORNTON JOSEPH CLAY Interim CFO Officer
Transaction date
Sale
Price
4.67
Quantity 4,630 -0.4%
Value US$21,622
1.3
Joseph Clay Thornton Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 4,486
Value US$20,994
3.5
Karen Soares Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 10,192
Value US$47,699
2.4
Jamie Reynoso Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 12,712
Value US$59,492
3.1
Andrew Toy Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 60,765
Value US$284,380
1.6
Conrad Wai Officer Officer
Transaction date
Proposed sale
Price
4.68
Quantity 23,463
Value US$109,807
2.4
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
4.68
Quantity 2,384 -0.1%
Value US$11,157
2.4
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
5.00
Quantity 2,384
Value US$11,920
2.4
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Sale
Price
5.26
Quantity 6,229 -0.2%
Value US$32,765
2.4
Jamie Reynoso Officer Officer
Transaction date
Proposed sale
Price
5.26
Quantity 6,229
Value US$32,765
3.1
Toy Andrew Chief Executive Officer Executive Director
Transaction date
Sale
Price
5.32
Quantity 313,476 -3.2%
Value US$1,667,692
3.1
Andrew Toy Officer Officer
Transaction date
Proposed sale
Price
5.39
Quantity 309,558
Value US$1,668,518
2.4
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
4.78
Quantity 2,360 -0.1%
Value US$11,281
2.4
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
4.94
Quantity 2,360
Value US$11,658
2.4
OLDAKOWSKI JOSEPH FRANK VP OF FINANCE AND CONTROLLER Officer
Transaction date
Sale
Price
4.86
Quantity 12,102 -3.9%
Value US$58,816
2.4
Joseph Frank Oldakowski Officer Officer
Transaction date
Proposed sale
Price
4.94
Quantity 14,155
Value US$69,926
3.5
Soares Karen Chief Legal Officer Officer
Transaction date
Sale
Price
4.61
Quantity 4,681 -0.3%
Value US$21,579
2.4
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Sale
Price
4.61
Quantity 6,350 -0.2%
Value US$29,274
3.5
Karen Soares Officer Officer
Transaction date
Proposed sale
Price
4.81
Quantity 5,342
Value US$25,695
2.4
Jamie Reynoso Officer Officer
Transaction date
Proposed sale
Price
4.81
Quantity 7,556
Value US$36,344
2.4
Reynoso Jamie L. CEO, Medicare Advantage Officer
Transaction date
Planned sale
Price
4.91
Quantity 7,289 -0.3%
Value US$35,789
2.4
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
4.89
Quantity 7,289
Value US$35,643
2.4
JAMIE REYNOSO Officer Officer
Transaction date
Proposed sale
Price
4.89
Quantity 7,289
Value US$35,643
1.6
Wai Conrad CEO, Counterpart Health Officer
Transaction date
Planned sale
Price
3.99
Quantity 220,426 -13.7%
Value US$879,500
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-17 2026-11-16 S Sale

Chief Financial Officer

Officer
22,161 -0.3%
384.11
US$84,252
22,161 -0.3% 384.11 US$84,252
2026-11-16 2026-11-16 PrS Proposed sale

Officer

Officer
15,034
335.02
US$2,970,696
15,034 335.02 US$2,970,696
2026-10-20 2026-10-20 PlS Planned sale

Chief Legal Officer

Officer
34,314 -20.4%
267.53
US$1,130,487
34,314 -20.4% 267.53 US$1,130,487
2026-10-20 2026-10-20 PrS Proposed sale

Officer

Officer
19,275
4.44
US$85,581
19,275 4.44 US$85,581
2026-10-20 2026-10-19 PlS Planned sale

CEO, Medicare Advantage

Officer
4,066 -0.1%
4.41
US$17,931
4,066 -0.1% 4.41 US$17,931
2026-10-19 2026-10-19 PrS Proposed sale

Officer

Officer
4,066
4.48
US$18,216
4,066 4.48 US$18,216
2026-10-19 2026-10-15 S Sale

Chief Executive Officer

Executive Director
62,176 -0.7%
4.68
US$290,984
62,176 -0.7% 4.68 US$290,984
2026-10-19 2026-10-15 S Sale

Chief Legal Officer

Officer
14,673 -0.9%
4.68
US$68,670
14,673 -0.9% 4.68 US$68,670
2026-10-19 2026-10-15 S Sale

Interim CFO

Officer
4,591 -0.4%
4.68
US$21,486
4,591 -0.4% 4.68 US$21,486
2026-10-19 2026-10-15 S Sale

CEO, Counterpart Health

Officer
23,627 -2.2%
4.68
US$110,574
23,627 -2.2% 4.68 US$110,574
2026-10-19 2026-10-15 S Sale

CEO, Medicare Advantage

Officer
18,273 -0.7%
4.68
US$85,518
18,273 -0.7% 4.68 US$85,518
2026-10-15 2026-10-15 PrS Proposed sale

Officer

Officer
60,765
4.68
US$284,380
60,765 4.68 US$284,380
2026-10-15 2026-10-15 PrS Proposed sale

Officer

Officer
4,487
4.68
US$20,999
4,487 4.68 US$20,999
2026-10-15 2026-10-15 PrS Proposed sale

Officer

Officer
23,463
4.68
US$109,807
23,463 4.68 US$109,807
2026-10-15 2026-10-15 PrS Proposed sale

Officer

Officer
14,341
4.68
US$67,116
14,341 4.68 US$67,116
2026-10-15 2026-10-15 PrS Proposed sale

Officer

Officer
17,858
4.68
US$83,575
17,858 4.68 US$83,575
2026-10-07 2026-10-07 PlS Planned sale

CEO, Medicare Advantage

Officer
2,006 -0.1%
4.63
US$9,288
2,006 -0.1% 4.63 US$9,288
2026-10-07 2026-10-07 PrS Proposed sale

Officer

Officer
2,006
4.60
US$9,228
2,006 4.60 US$9,228
2026-10-05 2026-10-05 S Sale

CEO, Medicare Advantage

Officer
8,750 -0.3%
4.42
US$38,675
8,750 -0.3% 4.42 US$38,675
2026-10-05 2026-10-05 PrS Proposed sale

Officer

Officer
8,706
4.68
US$40,744
8,706 4.68 US$40,744
2026-10-02 2026-10-01 S Sale

Chief Executive Officer

Executive Director
318,806 -3.4%
4.19
US$1,335,797
318,806 -3.4% 4.19 US$1,335,797
2026-10-01 2026-10-01 PrS Proposed sale

Officer

Officer
309,558
4.23
US$1,309,430
309,558 4.23 US$1,309,430
2026-09-24 2026-09-24 PrS Proposed sale

Former Officer

Officer
141,418
4.46
US$631,163
141,418 4.46 US$631,163
2026-09-18 2026-09-17 PlS Planned sale

CEO, Medicare Advantage

Officer
1,921 -0.1%
4.56
US$8,760
1,921 -0.1% 4.56 US$8,760
2026-09-17 2026-09-17 PrS Proposed sale

Officer

Officer
1,921
4.56
US$8,760
1,921 4.56 US$8,760
2026-09-17 2026-09-16 S Sale

VP OF FINANCE AND CONTROLLER

Officer
3,170 -1.1%
4.64
US$14,709
3,170 -1.1% 4.64 US$14,709
2026-09-16 2026-09-16 PrS Proposed sale

Officer

Officer
3,170
4.64
US$14,709
3,170 4.64 US$14,709
2026-09-16 2026-09-15 PlS Planned sale

CEO, Counterpart Health

Officer
300,000 -20.4%
4.72
US$1,416,000
300,000 -20.4% 4.72 US$1,416,000
2026-09-15 2026-09-15 S Sale

Chief Legal Officer

Officer
6,846 -0.4%
4.78
US$32,724
6,846 -0.4% 4.78 US$32,724
2026-09-15 2026-09-15 S Sale

CEO, Medicare Advantage

Officer
9,273 -0.3%
4.78
US$44,325
9,273 -0.3% 4.78 US$44,325
2026-09-15 2026-09-15 PrS Proposed sale

Officer

Officer
6,416
4.66
US$29,899
6,416 4.66 US$29,899
2026-09-15 2026-09-15 PrS Proposed sale

Officer

Officer
8,691
4.66
US$40,500
8,691 4.66 US$40,500
2026-09-15 2026-09-15 PrS Proposed sale

Former Officer

Officer
215,291
4.64
US$999,575
215,291 4.64 US$999,575
2026-09-15 2026-09-15 PrS Proposed sale

Officer

Officer
300,000
4.72
US$1,417,022
300,000 4.72 US$1,417,022
2026-09-14 2026-09-14 S Sale

VP OF FINANCE AND CONTROLLER

Officer
20,000 -6.7%
5.16
US$103,200
20,000 -6.7% 5.16 US$103,200
2026-09-14 2026-09-14 PrS Proposed sale

Officer

Officer
20,000
5.16
US$103,100
20,000 5.16 US$103,100
2026-08-31 2026-08-31 PrS Proposed sale

Officer

Officer
73,516
4.15
US$305,113
73,516 4.15 US$305,113
2026-08-17 2026-08-17 S Sale

Interim CFO

Officer
17,775 -1.4%
4.39
US$78,032
17,775 -1.4% 4.39 US$78,032
2026-08-17 2026-08-17 PrS Proposed sale

Officer

Officer
16,942
4.27
US$72,342
16,942 4.27 US$72,342
2026-08-14 2026-08-14 PrS Proposed sale

Officer

Officer
474,801
4.57
US$2,171,597
474,801 4.57 US$2,171,597
2026-08-10 2026-08-10 S Sale

Chief Executive Officer

Executive Director
87,798 -0.9%
4.65
US$408,261
87,798 -0.9% 4.65 US$408,261
2026-08-10 2026-08-10 PrS Proposed sale

Officer

Officer
85,704
4.57
US$391,667
85,704 4.57 US$391,667
2026-08-07 2026-08-07 PrS Proposed sale

Officer

Officer
441,601
4.85
US$2,141,989
441,601 4.85 US$2,141,989
2026-07-20 2026-07-20 PlS Planned sale

Chief Legal Officer

Officer
51,700 -3.3%
4.51
US$233,167
51,700 -3.3% 4.51 US$233,167
2026-07-20 2026-07-20 PrS Proposed sale

Officer

Officer
51,700
4.62
US$238,854
51,700 4.62 US$238,854
2026-07-17 2026-07-17 PlS Planned sale

CEO, Medicare Advantage

Officer
4,839 -0.2%
4.53
US$21,921
4,839 -0.2% 4.53 US$21,921
2026-07-17 2026-07-17 PrS Proposed sale

Officer

Officer
4,839
4.40
US$21,292
4,839 4.40 US$21,292
2026-07-16 2026-07-15 S Sale

Chief Executive Officer

Executive Director
62,711 -0.7%
4.67
US$292,860
62,711 -0.7% 4.67 US$292,860
2026-07-16 2026-07-15 S Sale

CEO, Counterpart Health

Officer
24,215 -2.1%
4.67
US$113,084
24,215 -2.1% 4.67 US$113,084
2026-07-16 2026-07-15 S Sale

CEO, Medicare Advantage

Officer
13,119 -0.5%
4.67
US$61,266
13,119 -0.5% 4.67 US$61,266
2026-07-16 2026-07-15 S Sale

Chief Legal Officer

Officer
10,519 -0.7%
4.67
US$49,124
10,519 -0.7% 4.67 US$49,124
2026-07-16 2026-07-15 S Sale

Interim CFO

Officer
4,630 -0.4%
4.67
US$21,622
4,630 -0.4% 4.67 US$21,622
2026-07-15 2026-07-15 PrS Proposed sale

Officer

Officer
4,486
4.68
US$20,994
4,486 4.68 US$20,994
2026-07-15 2026-07-15 PrS Proposed sale

Officer

Officer
10,192
4.68
US$47,699
10,192 4.68 US$47,699
2026-07-15 2026-07-15 PrS Proposed sale

Officer

Officer
12,712
4.68
US$59,492
12,712 4.68 US$59,492
2026-07-15 2026-07-15 PrS Proposed sale

Officer

Officer
60,765
4.68
US$284,380
60,765 4.68 US$284,380
2026-07-15 2026-07-15 PrS Proposed sale

Officer

Officer
23,463
4.68
US$109,807
23,463 4.68 US$109,807
2026-07-09 2026-07-08 PlS Planned sale

CEO, Medicare Advantage

Officer
2,384 -0.1%
4.68
US$11,157
2,384 -0.1% 4.68 US$11,157
2026-07-08 2026-07-08 PrS Proposed sale

Officer

Officer
2,384
5.00
US$11,920
2,384 5.00 US$11,920
2026-07-06 2026-07-06 S Sale

CEO, Medicare Advantage

Officer
6,229 -0.2%
5.26
US$32,765
6,229 -0.2% 5.26 US$32,765
2026-07-06 2026-07-06 PrS Proposed sale

Officer

Officer
6,229
5.26
US$32,765
6,229 5.26 US$32,765
2026-07-01 2026-07-01 S Sale

Chief Executive Officer

Executive Director
313,476 -3.2%
5.32
US$1,667,692
313,476 -3.2% 5.32 US$1,667,692
2026-07-01 2026-07-01 PrS Proposed sale

Officer

Officer
309,558
5.39
US$1,668,518
309,558 5.39 US$1,668,518
2026-06-18 2026-06-17 PlS Planned sale

CEO, Medicare Advantage

Officer
2,360 -0.1%
4.78
US$11,281
2,360 -0.1% 4.78 US$11,281
2026-06-17 2026-06-17 PrS Proposed sale

Officer

Officer
2,360
4.94
US$11,658
2,360 4.94 US$11,658
2026-06-17 2026-06-16 S Sale

VP OF FINANCE AND CONTROLLER

Officer
12,102 -3.9%
4.86
US$58,816
12,102 -3.9% 4.86 US$58,816
2026-06-16 2026-06-16 PrS Proposed sale

Officer

Officer
14,155
4.94
US$69,926
14,155 4.94 US$69,926
2026-06-16 2026-06-15 S Sale

Chief Legal Officer

Officer
4,681 -0.3%
4.61
US$21,579
4,681 -0.3% 4.61 US$21,579
2026-06-16 2026-06-15 S Sale

CEO, Medicare Advantage

Officer
6,350 -0.2%
4.61
US$29,274
6,350 -0.2% 4.61 US$29,274
2026-06-15 2026-06-15 PrS Proposed sale

Officer

Officer
5,342
4.81
US$25,695
5,342 4.81 US$25,695
2026-06-15 2026-06-15 PrS Proposed sale

Officer

Officer
7,556
4.81
US$36,344
7,556 4.81 US$36,344
2026-06-11 2026-06-11 PlS Planned sale

CEO, Medicare Advantage

Officer
7,289 -0.3%
4.91
US$35,789
7,289 -0.3% 4.91 US$35,789
2026-06-11 2026-06-11 PrS Proposed sale

Officer

Officer
7,289
4.89
US$35,643
7,289 4.89 US$35,643
2026-06-11 2026-06-11 PrS Proposed sale

Officer

Officer
7,289
4.89
US$35,643
7,289 4.89 US$35,643
2026-05-28 2026-05-28 PlS Planned sale

CEO, Counterpart Health

Officer
220,426 -13.7%
3.99
US$879,500
220,426 -13.7% 3.99 US$879,500

See older Clover Health Investments, Corp. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Clover Health Investments, Corp. history with Plus

Billed monthly · Cancel anytime